These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 23821267)

  • 1. A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures.
    Cai D; Nie H; Yan R; Guo JT; Block TM; Guo H
    Methods Mol Biol; 2013; 1030():151-61. PubMed ID: 23821267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and Reliable Protein-Free HBV DNA Extraction and Sensitive Branched DNA Southern Blot Assay.
    Yu M; Dandri M; Cheng G; Delaney WE; Fletcher SP; Allweiss L
    Methods Mol Biol; 2024; 2837():113-124. PubMed ID: 39044079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Hepatitis B Virus Covalently Closed Circular DNA and Intermediates in Its Formation.
    Hong X; Mendenhall MA; Hu J
    Methods Mol Biol; 2024; 2837():99-111. PubMed ID: 39044078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector.
    Lucifora J; Salvetti A; Marniquet X; Mailly L; Testoni B; Fusil F; Inchauspé A; Michelet M; Michel ML; Levrero M; Cortez P; Baumert TF; Cosset FL; Challier C; Zoulim F; Durantel D
    Antiviral Res; 2017 Sep; 145():14-19. PubMed ID: 28709657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Hepatitis B Virus Nuclear DNA.
    Li M; Sohn JA; Seeger C
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
    J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
    Takkenberg RB; Menting S; Beld MG
    Methods Mol Biol; 2012; 903():113-28. PubMed ID: 22782814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
    Nassal M
    Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance.
    Tu T; Zehnder B; Qu B; Ni Y; Main N; Allweiss L; Dandri M; Shackel N; George J; Urban S
    Antiviral Res; 2020 Sep; 181():104865. PubMed ID: 32726641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
    Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
    J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
    Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
    J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
    Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
    Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
    Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
    J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure.
    Allweiss L; Testoni B; Yu M; Lucifora J; Ko C; Qu B; Lütgehetmann M; Guo H; Urban S; Fletcher SP; Protzer U; Levrero M; Zoulim F; Dandri M
    Gut; 2023 May; 72(5):972-983. PubMed ID: 36707234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.
    Xia Y; Guo H
    Antiviral Res; 2020 Aug; 180():104824. PubMed ID: 32450266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.